Stakeholders ask for more clarity, risk-based approach in CGT, TEMP draft guidance
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGuidanceRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesGuidanceRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)